Italy's New Govt to Lower E-Cigarette Tax in Budget

Dec.09.2022
Italy's New Govt to Lower E-Cigarette Tax in Budget
Italy's new Meloni government plans to reduce taxes on e-cigarette liquid, providing relief for users and suppliers.

The new Meloni government in Italy has directly included a reduction in the consumption tax on e-cigarette liquid in the budget law. In fact, starting from January 2023, the tax on e-cigarette liquid will double due to the previous Conte government passing the budget law. For the uninitiated, all liquids intended for inhalation, whether containing nicotine or not, that are suitable for use with e-cigarettes are subject to appropriate consumption taxes just like traditional cigarettes as they belong to the national monopoly.


In summary, it appears that the price of e-cigarette liquid will remain steady starting in January. This will allow hundreds of thousands of Italian e-cigarette users to continue the habit of quitting smoking at a very low monthly cost. In fact, e-cigarettes have become an effective method for quitting smoking. Thanks to the new budget law, there will be no maximum increase (although the tax imposed on each bottle of alcohol will double), and the final decision will be made by the national accounting department. However, predictions are not just positive, but seem to be on the cover of everything. In short, this is good news for all participants in the e-cigarette supply chain, from e-liquid producers to retailers and end consumers, all of whom can breathe a sigh of relief. For some time now, e-cigarette retailers and manufacturers have been expecting news like this. Having a "fixed" tax that does not increase every year can allow you to expand production, distribution, and sales networks, increase job opportunities, and provide an effective tool to fight traditional smoking for more and more people.


After being sent to Brussels, the text of the budget law will be reviewed by the parliament and may be subject to modifications. However, statements from the government and armored figures from the parliament seem to ensure the certainty that Article 28 will not be altered. The same article also stipulates a slight increase in consumer tax on traditional tobacco (which actually occurs annually) in order to make up for the reduced tax on electronic and heated tobacco, which are considered lower-risk products. Assessing the current situation, the government has seemingly sent an important signal to the world of electronic cigarettes, an industry that employs tens of thousands in Italy.


In short, this is good news for loyal customers who use DEA flavored liquids, which are fully manufactured in Trento, Italy by one of the major players in the industry. Best-selling products under the DEA brand such as DEA Calliope, DEA Venere, DEA Nemesi, DEA Cuba liquids, and all other DEA brands will maintain their current prices next year.


Even DIY electronic cigarette enthusiasts stick to the concentrated flavors and neutral base they are accustomed to using. The infamous nicotine bristle remains the best-selling item in specialty stores and will maintain its price. These bristles are typically made up of just three components (propylene glycol, vegetable glycerin, and precise levels of nicotine chosen by the consumer) and play an important role for those who prefer to make their own liquid using certified and compliant products. Concentrated flavorings, like common food flavorings used for candies and cookies, are excluded from the national monopoly consumption tax. The vital first step taken by Meloni's government is hoped to provide a lifeline for the increasing number of citizens at present.


2FIRSTS will continue to follow and report on this issue, with further updates available on our app '2FIRSTSAPP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
Science | International Experts Propose a New Smoking Cessation Pathway, Citing Higher Quit Rates With E-Cigarettes Than Nicotine Replacement Therapy
A new expert paper in JAMA urges U.S. clinicians to include nicotine e-cigarettes in smoking-cessation discussions, citing higher quit rates than nicotine replacement therapy. It also stresses that products must deliver enough nicotine to replace cigarettes, dual use should be brief, and complete switching is the goal. 2Firsts argues the recommendations matter beyond clinics: public-health professionals should reassess relative risk, regulators should preserve sufficient product appeal for adult smokers, and manufacturers should focus on helping users quit cigarettes more sustainably.
SCIENCE
Aug.03 by 2Firsts Perspectives
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
South Korean electronics component supplier ITM Semiconductor is reshaping its business portfolio after a decline in Apple-related protection circuit business, expanding its supply of vape devices and cartridges to KT&G. According to News1 on August 18, 2026, ITM’s vape-related revenue rose 24.8% year on year to 75.5 billion won in the first half of 2026. The company began mass production of vape devices at its Cikarang, Indonesia facility in January 2026, strengthening export manufacturing capacity. Meanwhile, Samsung-related protection circuit sales continued to grow, providing support during the transition.
Aug.20
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
BREAKING | China’s Tobacco Regulator Summons iMiracle Over Suspected Compliance Breaches
Based on public records reviewed by 2Firsts, this is the first time China’s State Tobacco Monopoly Administration has publicly announced regulatory talks with an e-cigarette company.
Jul.29
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13